12Mar/13

Cardiac Biomarker ST2 Identifies Chronic Heart Failure Patients To Benefit … – PharmaLive (press release) (subscription)

Cardiac Biomarker ST2 Identifies Chronic Heart Failure Patients To Benefit
PharmaLive (press release) (subscription)
“ST2 is unlike any biomarker in heart failure because of its enduring prognostic strength, but now, as evidenced by the encouraging results from this study, ST2 holds the final link in potentially improving outcomes for heart failure patients through

and more »

12Mar/13

Anemia drugs does not improve health of anemic heart failure patients – EurekAlert (press release)


Health Newstrack

Anemia drugs does not improve health of anemic heart failure patients
EurekAlert (press release)
Researchers from Sahlgrenska Academy, University of Gothenburg, Sweden, have found that a commonly used drug to treat anemia in heart failure patients does not improve patients’ health, nor does it reduce their risk of death from heart failure. Results
ACC: Anemia Drug No Help in Heart FailureMedPage Today
Anemia treatment not beneficial in heart failureFamily Practice News Digital Network
ACC: Darbepoetin Alfa Doesn’t Up Outcome in Heart FailureDoctors Lounge
Forbes
all 5 news articles »
12Mar/13

Erectile dysfunction drug fails for diastolic heart failure patients – Science Codex


RedOrbit

Erectile dysfunction drug fails for diastolic heart failure patients
Science Codex
SAN FRANCISCO (March 11, 2013) — Despite high expectations for a commonly used erectile dysfunction drug to treat patients with diastolic heart failure, no beneficial effects were found in a study presented today at the American College of Cardiology
ASTRONAUT trial finds no beneficial effects of aliskiren in recently News-Medical.net
Viagra No Help in Heart FailureMedPage Today
Sildenafil falls short for heart failure with preserved ejection fractionFamily Practice News Digital Network
RedOrbit –French Tribune –Doctors Lounge
all 17 news articles »
12Mar/13

No benefit found from BP drug in treatment of recently hospitalized heart … – Medical Xpress

No benefit found from BP drug in treatment of recently hospitalized heart
Medical Xpress
Despite high hopes that a blood pressure-lowering medication called aliskiren would help people following hospitalization for heart failure, no beneficial effects were found, according to research presented today at the American College of Cardiology’s
Combination therapy for heart failure does not reduce risk of CV death or EurekAlert (press release)
Direct renin inhibitor aliskiren flops as add-on therapy in systolic HF: ASTRONAUTTheHeart.Org
ASTRONAUT Study: No Significant Post-Discharge Mortality Benefit Seen with Monthly Prescribing Reference

all 4 news articles »

12Mar/13

Erectile dysfunction drug fails for diastolic heart failure patients – EurekAlert (press release)


Zee News

Erectile dysfunction drug fails for diastolic heart failure patients
EurekAlert (press release)
SAN FRANCISCO (March 11, 2013) — Despite high expectations for a commonly used erectile dysfunction drug to treat patients with diastolic heart failure, no beneficial effects were found in a study presented today at the American College of Cardiology
Viagra `not helpful for heart failure patients`Zee News
Viagra is no help against heart failure: studyTimes LIVE
Viagra, Aliskiren Not Helpful for Heart Failure After All: StudiesHealth.com
Medical Xpress –RedOrbit –MedPage Today
all 12 news articles »
12Mar/13

CMV Prevention Drug Fast-Tracked by FDA – Monthly Prescribing Reference

CMV Prevention Drug Fast-Tracked by FDA
Monthly Prescribing Reference
Phase 2 clinical development of CMX001, for the prevention of CMV infection in adult hematopoietic stem cell transplant (HSCT) recipients, has been completed. Chimeric is planning on initiating SUPPRESS, a Phase 3 study of CMX001 for the prevention of
Chimerix antiviral lands on FDA’s fast trackWRAL Tech Wire
Chimerix receives FDA Fast Track designation for CMX001 to prevent CMV News-Medical.net

all 12 news articles »

12Mar/13

Digoxin reduces hospital admissions in older patients with chronic heart failure – EurekAlert (press release)

Digoxin reduces hospital admissions in older patients with chronic heart failure
EurekAlert (press release)
SAN FRANCISCO (March 11, 2013) —Digoxin significantly reduces the likelihood of hospital admission due to all causes among ambulatory older patients with chronic heart failure and reduced ejection fraction (HFrEF), according to research presented
Simple test can reduce heart failure riskIrish Health
Blood Test Plus Targeted Care May Stop Heart Failure Before It StartsHealth.com
ACC: Digoxin Cuts 30-Day Admission for Heart FailureDoctors Lounge

all 5 news articles »